Millie
your market intelligence analyst
Search Results
171 results
Your search is now limited to «Inflammation» expert search.
A study published earlier this year provided the first compelling evidence that inflammation in the mouth can increase your risk of Alzheimer’s.
More from Mail on Sunday (United Kingdom):
NaturalNews.com 09/19/2019 23:42
These inflammatory molecules accumulate and cause the pathology of disease, including but not limited to: Alzheimer’s.
More from NaturalNews.com:
News-Medical.net 09/19/2019 23:40
To confirm they had identified a potential drug target, Dr Martínez-Mármol knocked out the enzyme in mice with Alzheimer's disease and found the levels of plaques in the brain and the inflammatory response were all back to normal.
More from News-Medical.net:
BIOENGINEER.ORG 09/19/2019 13:26
The researchers suggest a comprehensive assessment of all the modifiable environmental factors associated with cognitive aging and Alzheimer’s disease, including diet, exercise, air pollution, socio-economic status, toxins, traumatic brain injuries, stress, inflammation, infections, hypertension, cells and gender.
More from BIOENGINEER.ORG:
FeedNavigator (EU) 09/19/2019 09:03
To date, most therapies for AD have targeted amyloid-β or tau.
More from FeedNavigator (EU):
Chem. Sci. , 2019, Accepted Manuscript DOI : 10.1039/C9SC03042E, Edge Article. Open Access. This article is licensed under a. Tao Yang, Zhenzhu Zhu, Enmao Yin, Yanqing Wang, Changli Zhang, Hao Yuan, Hongmei Zhang, Suxing Jin, Zijian Guo, Xiaoyong Wang Alzheimer’s disease (AD) is one of the most prevailing neurodegenerative illnesses in the elderly. Accumulation of amyloid-β peptide (Aβ) and inflammation play critical roles in the pathogenesis and development of... The content of this RSS Feed © The Royal Society of Chemistry.
ClinicalTrials.gov 09/18/2019 07:52
The present studies demonstrated that pro-inflammation, systemic oxidative stress and dysfunction in the brain-gut microbiota axis were involved in Alzheimer's disease (AD) pathogenesis.
More from ClinicalTrials.gov:
GlobeNewswire 09/18/2019 07:30
Patients treated with TTP399 had improved Time in Range (TIR), reduced time in hyperglycemia, fewer hypoglycemic events, and lower bolus insulin dose. Patients treated with TTP399 had improved Time in Range (TIR), reduced time in hyperglycemia, fewer hypoglycemic events, and lower bolus insulin dose.
More from GlobeNewswire:
Benzinga 09/17/2019 16:35
The thinly traded micro-cap biotech vTv Therapeutics Inc (NASDAQ: ) is on investors' radars ahead of a Sept. 18 poster presentation of clinical data. The company is set to present at the European Association for the Study of Diabetes 55th annual meeting with results from the Part 1 of the Phase 2 Simplici-T1 study of liver-selective glucokinase activator TTP399 as an adjunctive treatment for Type 1 diabetes. The Pipeline. vTv has six products in its clinical pipeline, with three Phase 2 assets: azeliragon for Alzheimer's disease, TTP399 for Type 1 and Type 2 diabetes and TTP273 for Type 2 diabetes. Azeliragon. codenamed TTP488, is an orally administered, small molecule antagonist targeting the receptor of advanced glycation endproducts, or RA.
More from Benzinga:
ENDPOINTS 09/17/2019 05:00
Psychedelics have experienced recent years amid a torrent of preclinical and clinical research suggesting it might provide a path to treat mood disorders conventional remedies have only scraped at. Now a preclinical trial from a young biotech suggests at least one psychedelic compound has effects beyond the mind, and — if you believe the still very, very early hype — could provide the first single remedy for some of the main complications of obesity. A study in mice funded by Eleusis and published in Scientific Reports found a long-known drug called ®-DOI could be used to treat cardiovascular disease, reducing inflammation in the aorta, decreasing overall and HDL cholesterol levels, and potentially curbing diabetes by increasing glucose tol.
Innovations-Report (EU) 09/16/2019 10:35
Researchers at the Complutense University of Madrid (UCM) have identified changes in retinal layer thickness, inflammation or thinning in patients with mild Alzheimer's disease, confirming that the retina is one of the most important biomarkers for early diagnosis of the disease. For the first time, researchers have determined the shape and size of the areas that present significant thinning in each retinal layer, which tend to occur in...
PubMed News (NIH) 09/16/2019
Contributors : Christoph Gericke ; Anna Mallone ; Britta Engelhardt ; Roger M Nitsch ; Maria T Ferretti Series Type : Expression profiling by high throughput sequencing Organism : Mus musculus. The goal of this study is to investigate the involvement of inflammation in Alzheimer’s disease (AD) and to clarify the signaling pathways involved in the presence of beta-amyloidosis, a hallmark of AD pathogenesis, to help identifying potential targets for therapy.
More from PubMed News (NIH):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications